ON THE ORIGIN OF LUNG CANCER DEVELOPMENT

Authors

  • L.S. Bolgova National Cancer Institute, Ministry of Health of Ukraine, Kyiv 03022, Ukraine
  • T.N. Tuganova National Cancer Institute, Ministry of Health of Ukraine, Kyiv 03022, Ukraine
  • O.I. Alekseenko National Cancer Institute, Ministry of Health of Ukraine, Kyiv 03022, Ukraine
  • A.A. Ponomarenko National University of Kyiv Mohyla Academy

DOI:

https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-1.17227

Keywords:

alveolar epithelium, histogenesis, lung cancer, stem cells

Abstract

In the review on the issues of histogenesis of lung cancer (LC), the significant results of experimental, pathological, immunohistochemical and molecular-biological studies are presented. However, until now, no data has been obtained that would allow scientists to come to an unambiguous decision about the origin and development of this disease. The question remains not yet fully understood, since researchers discuss the origin of LC development in a hypothetical form. This situation poses the task of further in-depth scientific research, which would make it possible to clarify the unambiguous origin of LC development, and, therefore, would allow solving the problem of its early diagnosis and create grounds for screening programs, which is of high scientific and clinical significance.

References

Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209–49. https://doi.org/10.3322/caac.21660

Pennycuick A, Janes SM. On the origin of lung cancer. Am J Respir Crit Care Med 2020; 201: 646-7. https://doi.org/10.1164/rccm.201911-2176ED

Fedorenko Z, Michailovich Yu, Goulak L, et al. Cancer in Ukraine: 2018–2019: incidence, mortality, rates of activity of oncological service. Bull Nat Cancer Registry of Ukraine 2020; 2: 33–4.

Verovkina N. Recent advances in immunotherapy in the treatment of cancer patients: the use of immunotherapy in non-small cell lung cancer. Clin Oncologiya 2018; 8: 228–31 (in Ukrainian).

Semenova E, Nage lR, Berns A. Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes Dev 2015; 29: 1447–62. https://doi.org/10.1101/gad.263145.115

Grigoryeva E, Kokova D, Gratchev A, et al. Smoking-related DNA adducts as potential diagnostic markers of lung cancer: new perspectives. Exp Oncol 2015; 37: 5–12.

Sainz de Aja J, Dost AFM, Kim CF. Alveolar progenitor cells and the origin of lung cancer. J Intern Med 2020; 289: 629–35. https://doi.org/10.1111/joim.13201

Hanna JM, Onaitis MW. Cell of origin of lung cancer. J Carcinog 2013; 12: 6–11. https://doi.org/10.4103/1477-3163.109033

Bolgova L, Tuganova T. Lung Cancer: Issues of Histogenesis and Cytological Diagnosis. Kyiv: KIM, 2013. 168 p. (in Russian).

Travis W, Nicholson S, Hirsch FR, et al. Small cell carcinoma. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, 2004. 31–4.

Kogan E, Kodolova I, Sekamova S. Morphogenesis of peripheral lung cancer. Arch Pathol 1988; 50: 26–34 (in Russian).

Ferone G, Lee MC, Sage J, et al. Cells of origin of lung cancers: lessons from mouse studies. Genes Dev 2020; 34: 1017–32. https://doi.org/10.1101/gad.338228.120

Zamay TN, Zamay GS, Kolovskaya OS, et al. Current and prospective protein biomarkers of lung cancer. Cancers 2017; 9: 155. https://doi.org/10.3390/cancers9110155

Bolgova L, Yaroshuk Т. Histogenesis of lung cancer. Vopr Oncol 2010; 56: 469–76 (in Russian).

Ten Have-Opbroek AA, Benfield JR, van Krieken JH, et al. The alveolar type II cell in the genesis of human adenocarcinomas and squamous cell carcinomas. Histol Histopathol 1997; 12: 319–36.

Travis WD, Brambilla E, Burke AP, et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, 2015. 412 p.

Brambilla E, Travis WD. Adenosquamous carcinoma. World Health Organization Classification of Tumours. Patho­logy and genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, 2004: 51–2.

Colby TV, Noguchi M, Henschke C, et al. Tumours of the Lung. Adenocarcinoma. Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, 2004: 35.

Kogan Ye. Precancer and lung cancer. Arch Pathol 1989; 51: 76–83 (in Russian).

Erokhin V, Romanova L. Lung Cell Biology in Norm and Pathology. M: Medicina, 2000. 496 p. (in Russian).

de Sousa VML, Carvalho L. Heterogeneity in lung cancer. Pathobiology 2018; 85: 96–107. https://doi.org/10.1159/000487440

Chen Z, Fillmore CM, Hammerman PS, et al. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer 2014; 14: 535–46. https://doi.org/10.1038/nrc3775

Kitamura H, Kameda Y, Ito T, et al. Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma. Am J Clin Pathol 1999; 111: 610–22. https://doi.org/10.1093/ajcp/111.5.610

Okudela K, Kojima Y, Matsumura M, et al. Relationship between non-TRU lung adenocarcinomas and bronchiolar metaplasia — potential implication in their histogenesis. Histol Histopathol 2018; 33: 317–26. https://doi.org/10.14670/HH-11-935

Salahudeen AA, Choi SS, Rustagi A, et al. Progenitor identification and SARS-CoV-2 infection in human distal lung organoids. Nature 2020; 588: 670–5. https://doi.org/10.1038/s41586-020-3014-1

Nepomnyashchikh G. Bronchial Biopsy: Morphogenesis of General Biological Processes in the Lungs. M: RANM, 2005. 384 p (in Russian).

Kato T, Oka K, Nakamura T, Ito A. Bronchioalveolar morphogenesis of human bronchial epithelial cells depending upon hepatocyte growth factor. J Cell Mol Med 2015; 19: 2818–26. https://doi.org/10.1111/jcmm.12672

Takahashi K. Multiple primary lung cancer including preinvasive squamous cancer and peripheral adenocarcinoma. Lung Cancer 1983; 23: 527–35.

Gazdar A, Franklin WA, Brambilla E, et al. Genetic and molecular alterations. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, 2004: 21.

Desai TJ, Brownfield DG, Krasnow MA. Alveolar progenitor and stem cells in lung development, renewal and cancer. Nature 2014; 507: 190–4. https://doi.org/10.1038/nature12930

Situ D, Wang J, Ma Y, et al. Expression and prognostic relevance of MUC1 in stage IB non-small cell lung cancer. Med Oncol 2011; 28: 596–604. https://doi.org/10.1007/s12032-010-9752-4

Guida F, Sun N, Bantis LE, et al. Assessment of lung cancer risk on the basis of a biomarker panel of circulating proteins. JAMA Oncol 2018; 4: e182078. https://doi.org/10.1001/jamaoncol.2018.2078

Quint LE, Tummala S, Brisson LJ, et al. Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg 1996; 62: 246–50. https://doi.org/10.1016/0003-4975(96)00220-2

Tetsushi I, Harubumi K, Chimori K, et al. A case of roentgenographically occult triple lung cancer. Haigan Lung Cancer 1988; 28: 895–900. https://doi.org/10.2482/haigan.28.895

Bolgova L, Tuganova T, Alekseenko O, et al. Histogenesis of central lung cancer: cytological investigation. Exp Oncol 2020; 4: 310–3. https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-4.15232

Giangreco A, Reynolds SD, Stripp BR. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol 2002; 161: 173–82. https://doi.org/10.1016/S0002-9440(10)64169-7

Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioloalveolar stem cells in normal lung and lung cancer. Cell 2005; 121: 823–35. https://doi.org/10.1016/j.cell.2005.03.032

Rawlins EL, Okubo T, Xue Y, et al. The role of Scgblal + Clara cell in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell 2009; 4: 525–34. https://doi.org/10.1016/j.stem.2009.04.002

Xu J, Yu Q, Liu X. [Proximal bronchial invasion of lung cancer: a clinicopathological study]. Zhonghua Zhong Liu Za Zhi 1998; 20: 448–50 (in Chinese).

Takahashi RT, Hisashi N, Yuji M, et al. Cancer surveillance with growth as a polip in pulmonary bull. Haigan Lung Cancer 1999; 39: 165–70.

Pingxin L, Xinhua Z, Baojian L, Xiaogang R. The CT findings of endobronchial spread in lung adenocarcinoma. Chin J Radiol 2007; 41: 475–9 (in Chinese).

Netter F. Atlas of Human Anatomy. 7 ed. Elsevier, 2019. 791 p.

Esipova I. Lung in Pathology. Part I. Nauka, 1975. 212 p (in Russian).

Gricjute LA. Experimental Lung Tumours. M: Medicina, 1975. 166 p (in Russian).

Vesnushkin G, Plotnikova N, Semenchenko A, et al. Melatonin inhibits urethane-induced lung cancerogenesis in mice. Vopr Oncol 2006; 52: 164–8 (in Russian).

Weibel ER. Morphometry of Human Lungs. M: Medicina, 1970. 174 p (in Russian).

Heng WS, Gosens R, Kruyt F. Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting. Biochem Pharmacol 2019; 160: 121–33. https://doi.org/10.1016/j.bcp.2018.12.010

Zagorulko A, Askari T. Atlas of Ultrastructural Morphology of Respiratory Department. Simferopol: AZ-PRESS — SONAT, 2002. 142 p (in Russian).

Romanova L. Regulation of Recovery Processes. Publishing House of Moscow University, 1984. 174 p (in Russian).

Ivanov G. Basis of Normal Human Anatomy. Part I. M: Medgiz, 1949. 650 p (in Russian).

Reynolds SD, Giangreco A, Power JT, Stripp BR. Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am J Pathol 2000; 156: 269–78. https://doi.org/10.1016/S0002-9440(10)64727-X

Xu X, Rock JR, Lu Y, et al. Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma. Proc Natl Acad Sci USA 2012; 109: 4910–5. https://doi.org/10.1073/pnas.1112499109

Bertoncello I. Stem Cells in the Lung. Development, Repair and Regeneration. Springer, 2015. 366 p. https://doi.org/10.1007/978-3-319-21082-7

Liu X, Engelhardt JF. The glandular stem/progenitor cell niche in airway development and repair. Proc Am Thorac Soc 2008; 5: 682–8. https://doi.org/10.1513/pats.200801-003AW

Sneddon JB, Werb Z. Location, location, location: the cancer stem cells niche. Cell Stem Cell 2007; 1: 607–11. https://doi.org/10.1016/j.stem.2007.11.009

Navarro S, Driscoll B. Regeneration of the aging lung: A mini-review. Gerontology 2017; 63: 270–80. https://doi.org/10.1159/000451081

Esipova I. Lung in Normal Condition. Novosibirsk: Nauka, 1975: 30. (in Russian).

Maksimovich N. Pathological anatomy of acute respiratory diseases and their importance in child mortality. Arch Pathol 1980; 7: 20–4 (in Russian).

Kogan E, Kichigina O, Demura S, et al. Morphological, immunohistochemical and radiological manifestations of pulmonary tissue remodeling with sarcoidosis of the lung. Arch Path 2012; 74: 37–43 (in Russian).

Kathiriya JJ, Brumwell AN, Jackson JR, et al. Distinct airway epithelial stem cells hide among club cells but mobilize to promote alveolar regeneration. Cell Stem Cell 2020; 26: 346–58. https://doi.org/10.1016/j.stem.2019.12.014

Sutherland KD, Berns A. Cell of origin of lung cancer. Mol Oncol 2010; 4: 397–403. https://doi.org/10.1016/j.molonc.2010.05.002

Downloads

Published

26.05.2023

How to Cite

Bolgova, L., Tuganova, T., Alekseenko, O., & Ponomarenko, A. (2023). ON THE ORIGIN OF LUNG CANCER DEVELOPMENT. Experimental Oncology, 44(1), 17–22. https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-1.17227